Works matching AU Comi, M.


Results: 42
    1

    The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder.

    Published in:
    Human Mutation, 2022, v. 43, n. 2, p. 266, doi. 10.1002/humu.24308
    By:
    • Kumble, Smitha;
    • Levy, Amanda M.;
    • Punetha, Jaya;
    • Gao, Hua;
    • Ah Mew, Nicholas;
    • Anyane‐Yeboa, Kwame;
    • Benke, Paul J.;
    • Berger, Sara M.;
    • Bjerglund, Lise;
    • Campos‐Xavier, Belinda;
    • Ciliberto, Michael;
    • Cohen, Julie S.;
    • Comi, Anne M.;
    • Curry, Cynthia;
    • Damaj, Lena;
    • Denommé‐Pichon, Anne‐Sophie;
    • Emrick, Lisa;
    • Faivre, Laurence;
    • Fasano, Mary Beth;
    • Fiévet, Alice
    Publication type:
    Article
    2
    3

    Urine vascular biomarkers in Sturge–Weber syndrome.

    Published in:
    Vascular Medicine, 2013, v. 18, n. 3, p. 122, doi. 10.1177/1358863X13486312
    By:
    • Sreenivasan, Aditya K;
    • Bachur, Catherine D;
    • Lanier, Kira E;
    • Curatolo, Adam S;
    • Connors, Susan M;
    • Moses, Marsha A;
    • Comi, Anne M
    Publication type:
    Article
    4
    5
    6

    Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study.

    Published in:
    European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 6, p. 1149, doi. 10.1007/s10096-024-04833-8
    By:
    • Oliva, Alessandra;
    • Liguori, L;
    • Covino, S;
    • Petrucci, F;
    • Cogliati-Dezza, F;
    • Curtolo, A;
    • Savelloni, G;
    • Comi, M;
    • Sacco, F;
    • Ceccarelli, G;
    • Viscido, A;
    • Alessandri, F;
    • Raponi, G;
    • Pugliese, F;
    • Mastroianni, CM;
    • Venditti, M
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Survey of Aspirin Use in Sturge-Weber Syndrome.

    Published in:
    Journal of Child Neurology, 2011, v. 26, n. 6, p. 692, doi. 10.1177/0883073810388646
    By:
    • Bay, Mihee J.;
    • Kossoff, Eric H.;
    • Lehmann, Christoph U.;
    • Zabel, T. Andrew;
    • Comi, Anne M.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment‐resistant epilepsies in the Expanded Access Program.

    Published in:
    Epilepsia (Series 4), 2023, v. 64, n. 8, p. e156, doi. 10.1111/epi.17665
    By:
    • Flamini, Robert J.;
    • Comi, Anne M.;
    • Bebin, E. Martina;
    • Chez, Michael G.;
    • Clark, Gary;
    • Devinsky, Orrin;
    • Hussain, Shaun A.;
    • Lyons, Paul D.;
    • Patel, Anup D.;
    • Rosengard, Jillian L.;
    • Sahebkar, Farhad;
    • Segal, Eric;
    • Seltzer, Laurie;
    • Szaflarski, Jerzy P.;
    • Weinstock, Arie
    Publication type:
    Article
    37

    Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results.

    Published in:
    Epilepsia (Series 4), 2018, v. 59, n. 8, p. 1540, doi. 10.1111/epi.14477
    By:
    • Szaflarski, Jerzy P.;
    • Bebin, Elizabeth Martina;
    • Comi, Anne M.;
    • Patel, Anup D.;
    • Joshi, Charuta;
    • Checketts, Daniel;
    • Beal, Jules C.;
    • Laux, Linda C.;
    • De Boer, Lisa M.;
    • Wong, Matthew H.;
    • Lopez, Merrick;
    • Devinsky, Orrin;
    • Lyons, Paul D.;
    • Zentil, Pilar Pichon;
    • Wechsler, Robert;
    • CBD EAP study group
    Publication type:
    Article
    38
    39
    40
    41
    42